Refine
Has Fulltext
- yes (9)
Is part of the Bibliography
- yes (9)
Year of publication
- 2020 (9) (remove)
Document Type
- Journal article (8)
- Preprint (1)
Language
- English (9)
Keywords
- boron (3)
- prodrug (2)
- rhodesain (2)
- 1,4-naphthoquinone (1)
- Acene (1)
- African sleeping sickness (1)
- Bindungsaktivierung (1)
- Biradikale (1)
- Bor (1)
- Boranes (1)
- Borylene (1)
- Diborene (1)
- EDA-NOCV (1)
- Heterocyclen (1)
- Meisenheimer complex (1)
- NMR spectroscopy (1)
- Photoelektronenspektroskopie (1)
- acenes (1)
- biradicals (1)
- bond Activation (1)
- bonding (1)
- carbenes (1)
- conjugation (1)
- covalent inhibitors (1)
- covalent reversible inhibition (1)
- cysteine protease (1)
- density-functional calculations (1)
- diborenes (1)
- electrophilic (het)arene (1)
- heterocycles (1)
- methylbismuth (1)
- nucleophilic addition (1)
- nucleophilic aromatic substitution (1)
- oxidative addition (1)
- platinum (1)
- protease (1)
- quantum chemistry (1)
- rearrangements (1)
- structural biology (1)
- structure elucidation (1)
- π-complex (1)
Institute
Sonstige beteiligte Institutionen
EU-Project number / Contract (GA) number
- 669054 (2)
The facile synthesis and detailed investigation of a class of highly potent protease inhibitors based on 1,4-naphthoquinones with a dipeptidic recognition motif (HN-l-Phe-l-Leu-OR) in the 2-position and an electron-withdrawing group (EWG) in the 3-position is presented. One of the compound representatives, namely the acid with EWG = CN and with R = H proved to be a highly potent rhodesain inhibitor with nanomolar affinity. The respective benzyl ester (R = Bn) was found to be hydrolyzed by the target enzyme itself yielding the free acid. Detailed kinetic and mass spectrometry studies revealed a reversible covalent binding mode. Theoretical calculations with different density functionals (DFT) as well as wavefunction-based approaches were performed to elucidate the mode of action.